The effects of non-specifically activated immunity in rabbits on primary infestation with Rhipicephalus evertsi evertsi

The secondary antibody response to sheep red blood cells and bovine serum albumin (BSA) was measured in rabbits infested with adult Rhipicephalus evertsi evertsi. The response was reduced (particularly for BSA) but still displayed anamnestic characteristics. Resistance against ixodid ticks associated with antibodies detected by gel diffusion and enzyme linked immunosorbent assay techniques early in the primary challenge was acquired by the immunized hosts only. This suggests that a non-specifically activated immune system enables hosts to develop rapid resistance against tick parasitism.     

广西部分地区猪群主要疫病免疫抗体监测和免疫效果分析

从广西5个地市33家养殖场随机采集免疫过猪繁殖与呼吸综合征(PRRS)、猪瘟(CSF)、猪伪狂犬病(PR)疫苗的血清样品393份,使用免疫胶体金方法对样品的抗体水平进行检测。结果显示,不同养殖规模的猪场抗体阳性率总体较高的是猪瘟,达75.06%;其次是猪伪狂犬病,为71.25%;而猪繁殖与呼吸综合征抗体最低,仅为42.24%。各种病原抗体在不同规模的猪场有较大的差别,规模猪场的猪群某些疫病的抗体未必比散养猪群高。通过对不同类型的疫苗所产生的抗体水平进行比较,结果发现,使用猪繁殖与呼吸综合征灭活苗和弱毒苗、猪瘟脾淋苗和细胞苗、猪伪狂犬病国产苗和进口苗免疫所产生的抗体水平没有明显差异。     

猪繁殖与呼吸综合征母源抗体和免疫抗体的消长规律研究

为制定科学的免疫程序,从根本上控制猪繁殖与呼吸综合征的发生,用ELISA诊断试剂盒分别对母猪、仔猪进行了母源抗体和免疫抗体检测。试验证明母猪在配种前15 d首免,怀孕2个月时二免,在下一次配种前15 d再免,如此按生产周期免疫可以抵抗猪繁殖与呼吸综合征的感染。在母猪产前1个月免疫猪繁殖与呼吸综合征灭活疫苗,所产仔猪母源抗体60日龄时为阴性,故45日龄左右对仔猪进行首免最佳,为确定仔猪首免日龄提供了理论依据。对40日龄仔猪免疫猪繁殖与呼吸综合征灭活疫苗后,仔猪58日龄时抗体S/P平均值最高,到160日龄育肥猪时抗体S/P平均值为阴性,这时不能抵抗猪繁殖与呼吸综合征的感染。对40日龄仔猪肌肉注射2 mL猪繁殖与呼吸综合征灭活疫苗,70日龄同剂量二免,85日龄时抗体S/P值平均值最高,到180日龄育肥猪时抗体S/P平均值仍为阳性,还能抵抗猪繁殖与呼吸综合征的感染,如果作为肉猪可以安全上市;作为后备母猪,在配种前进行免疫即可。非免疫母猪、仔猪对照组抗体均为阴性。通过试验基本上查明了猪繁殖与呼吸综合征母源抗体和免疫抗体的消长规律,为以后制定免疫程序提供了理论依据。     

蛋鸡免疫重组禽流感病毒H_5亚型二价灭活疫苗抗体消长规律的研究

为了在临床上制定合理的禽流感疫苗免疫程序,用重组禽流感病毒H_5亚型二价灭活疫苗(H_5N_1,Re-5株+Re-4株)分别在14日龄、49日龄、105日龄免疫蛋鸡,免疫剂量分别为0.3ml/只、0.5ml/只、0.5ml/只。分别在第1、6、10、14、20、28、35、42、49、56、63、70、77、86、94、105、120、150、180日龄采血测定HI抗体效价。结果表明首免后HI抗体上升较慢较低,只有第二次免疫后,抗体才迅速升高。在70日龄(二免后3周)H5N1,Re-4HI抗体达到9.60log2,H_5N_1,Re-5HI抗体达到7.86log2。在120日龄(三免后2周)H_5N_1,Re-4HI抗体达到9.30log2,H_5N_1,Re-5HI抗体达到9.25log2。     

猪伪狂犬病病毒gE抗体胶体金免疫层析检测方法的建立及应用

以纯化的抗人红细胞单链抗体(ScFv)-猪伪狂犬病病毒(PRV)gE蛋白双功能融合蛋白为诊断抗原和胶体金标记物,以羊抗猪IgG包被硝酸纤维膜作为质控带,制作检测猪伪狂犬病毒gE抗体的双抗原胶体金试纸条。利用方阵滴定试验筛选出金标抗原最佳工作浓度为17.6μg,检测线诊断抗原最佳标记量为1.76μg,血清最佳稀释度为1∶10,作用时间15 min,与猪瘟病毒(CSFV)、猪细小病毒(PPV)、猪繁殖与呼吸综合征病毒(PRRSV)、猪乙型脑炎病毒(JEV)、猪布鲁菌(Brucella)阳性血清和PRVgE缺失疫苗接种的猪免疫血清检测线均不出现红色条带,与PRV标准阳性血清反应检测线出现红色条带。试纸条操作简单,肉眼于15 min内可判定结果;试纸条在室温保存6个月,其特异性和敏感性没有明显变化;与美国IDEXX和法国LSI gE-ELISA抗体检测诊断试剂盒检测结果比较,1 164份猪血清的符合率均为90.55%。制备的胶体金试纸条具有操作简便、敏感性和特异性较高的特点,可用于PRV野毒感染的快速筛查。     

禽白血病病毒J亚群(ALV-J)的攻毒试验

将禽白血病病毒 J亚群 (AL V- J)内蒙株 NM876 1和 NM9996人工接种于 1日龄爱维茵肉种鸡 ,通过眼观、病理组织学检查观察了攻毒鸡的病理学特征 ;通过 PCR和 EL ISA技术检测了病毒感染率、抗体变化规律以及病毒和抗体的相关性。结果显示 ,攻毒鸡从第 3周开始即可检出病毒 ,NM876 1株和 NM9996株病毒感染率分别为 71.4 %和6 4 .3% ;从第 5周开始 ,出现较明显的病理学变化 ,病变特征以骨髓、肝脏、心脏、脾、卵巢等组织内髓细胞增生为主 ,而法氏囊、脑、坐骨神经无变化 ;攻毒鸡抗体消长变化有一定的规律 ,一般在 7～ 8周龄和 18～ 2 0周龄时分别出现 1次高峰 ,而在 4～ 6周龄、10周龄和 2 3周龄分别出现 1次低谷 ,提示鸡场进行 EL ISA检测时要避开这一时期 ;攻毒鸡产生耐受性病毒血症 ,即病毒阳性而抗体阴性 (V A- )的比例较高 (7/14 ,9/14 )。通过以上的研究证明 ,AL V- J内蒙株疾病模型复制成功 ,NM876 1、NM9996可作为原型株进行相关研究     

用酶联免疫吸附和正向间接血凝试验检测猪瘟抗体

应用ELISA和IHA对我省两种猪场的66份血清进行了检测,结果表明用ELISA检测两猪场免疫合格率分别为83.33%、80.5%,用IHA检测分别为90%、97.2%;两者检测结果符合率为84.8%,具有较高的群体相关性。     

Dot-ELISA检测兔疥螨抗体方法的建立和应用

将从病兔痂皮内收集的疥螨经研磨、冻融、离心后,制成可溶性抗原,作为诊断抗原,建立Dot-ELISA方法检测兔疥螨血清抗体.研究确定了该方法的最佳工作条件.制备的诊断膜片特异性强,不与兔瘟病毒、兔大肠埃希菌、兔附红细胞体等阳性血清反应.膜片具有良好的灵敏性,高免血清作1∶210稀释亦能检出;重复性试验表明该法重复性良好.诊断膜片在4 ℃保存5个月其检测活性不变.结果表明,建立的Dot-ELISA可用于免疥螨抗体的检测.     

Development and validation of an improved enzyme-linked immunosorbent assay for the detection of thyroglobulin autoantibodies in canine serum samples

An enzyme-linked immunosorbent assay to detect thyroglobulin autoantibodies (TGAB) in canine serum was developed and validated. The test result for each sample was derived from the optical density readings (OD) and expressed as an Ab-score(%) calculated from three in-house calibrators. The assay specifically detected TGAB as judged from lack of response in the assay after samples had been incubated with specific antigen. Intra- and interassay coefficients of variation ranged from 2.0–4.9% and 4.6–9.9%, respectively. The detection limit, an Ab-score of 5.6%, was close to the median Ab-score of 10% observed in healthy dogs (n = 132). The median Ab-score of dogs with primary hypothyroidism and lymphocytic thyroiditis (n = 11), skin diseases (n = 35), and non-thyroidal diseases (n = 63) was 340%, 12%, and 8%, respectively. The prevalence of TGAB in hypothyroid dogs with lymphocytic thyroiditis (sensitivity) was 91% (95% confidence limits: 59%–99%). In dogs with dermatological diseases without lymphocytic thyroiditis the prevalence of TGAB was 3% corresponding to a specificity of 97% (95% confidence limit: 85%–100%). In dogs with non-thyroidal diseases and healthy dogs the prevalence of TGAB was 5% and 6%, respectively. The diagnostic accuracy of serum TGAB was evaluated by subjecting the data from 11 dogs with lymphocytic thyroiditis and 35 control dogs without lymphocytic thyroiditis to receiver-operating characteristic curve analysis. The area under the receiver-operating characteristic curve (W = 0.966; 95% confidence limit 87%–100%) was significantly higher than that of a worthless test (0.5) (P < 0.0001), thereby indicating that serum TGAB measurements distinguished between dogs with and without lymphocytic thyroiditis.     

DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens

The H5 gene of avian influenza virus (AIV) strain A/chicken/Malaysia/5744/2004(H5N1) was cloned into pcDNA3.1 vector, and Esat-6 gene of Mycobacterium tuberculosis was fused into downstream of the H5 gene as a genetic adjuvant for DNA vaccine candidates. The antibody level against AIV was measured using enzyme-linked immunosorbent assay (ELISA) and haemagglutination inhibition (HI) test. Sera obtained from specific-pathogen-free chickens immunized with pcDNA3.1/H5 and pcDNA3.1/H5/Esat-6 demonstrated antibody responses as early as 2 weeks after the first immunization. Furthermore, the overall HI antibody titer in chickens immunized with pcDNA3.1/H5/Esat-6 was higher compared to the chickens immunized with pcDNA3.1/H5 (p < 0.05). The results suggested that Esat-6 gene of M. tuberculosis is a potential genetic adjuvant for the development of effective H5 DNA vaccine in chickens.